Literature DB >> 26794651

Neurodegenerative disease in 2015: Targeting tauopathies for therapeutic translation.

Julio C Rojas1, Adam L Boxer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26794651      PMCID: PMC5221610          DOI: 10.1038/nrneurol.2016.5

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  8 in total

1.  Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.

Authors:  Sukriti Nag; Lei Yu; Ana W Capuano; Robert S Wilson; Sue E Leurgans; David A Bennett; Julie A Schneider
Journal:  Ann Neurol       Date:  2015-04-22       Impact factor: 10.422

2.  Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.

Authors:  Günter U Höglinger; Nadine M Melhem; Dennis W Dickson; Patrick M A Sleiman; Li-San Wang; Lambertus Klei; Rosa Rademakers; Rohan de Silva; Irene Litvan; David E Riley; John C van Swieten; Peter Heutink; Zbigniew K Wszolek; Ryan J Uitti; Jana Vandrovcova; Howard I Hurtig; Rachel G Gross; Walter Maetzler; Stefano Goldwurm; Eduardo Tolosa; Barbara Borroni; Pau Pastor; Laura B Cantwell; Mi Ryung Han; Allissa Dillman; Marcel P van der Brug; J Raphael Gibbs; Mark R Cookson; Dena G Hernandez; Andrew B Singleton; Matthew J Farrer; Chang-En Yu; Lawrence I Golbe; Tamas Revesz; John Hardy; Andrew J Lees; Bernie Devlin; Hakon Hakonarson; Ulrich Müller; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-06-19       Impact factor: 38.330

3.  Peripheral Total Tau in Military Personnel Who Sustain Traumatic Brain Injuries During Deployment.

Authors:  Anlys Olivera; Natasha Lejbman; Andreas Jeromin; Louis M French; Hyung-Suk Kim; Ann Cashion; Vincent Mysliwiec; Ramon Diaz-Arrastia; Jessica Gill
Journal:  JAMA Neurol       Date:  2015-10       Impact factor: 18.302

4.  The neuropathology of probable Alzheimer disease and mild cognitive impairment.

Authors:  Julie A Schneider; Zoe Arvanitakis; Sue E Leurgans; David A Bennett
Journal:  Ann Neurol       Date:  2009-08       Impact factor: 10.422

5.  Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.

Authors:  Jonathan D Rohrer; Jennifer M Nicholas; David M Cash; John van Swieten; Elise Dopper; Lize Jiskoot; Rick van Minkelen; Serge A Rombouts; M Jorge Cardoso; Shona Clegg; Miklos Espak; Simon Mead; David L Thomas; Enrico De Vita; Mario Masellis; Sandra E Black; Morris Freedman; Ron Keren; Bradley J MacIntosh; Ekaterina Rogaeva; David Tang-Wai; Maria Carmela Tartaglia; Robert Laforce; Fabrizio Tagliavini; Pietro Tiraboschi; Veronica Redaelli; Sara Prioni; Marina Grisoli; Barbara Borroni; Alessandro Padovani; Daniela Galimberti; Elio Scarpini; Andrea Arighi; Giorgio Fumagalli; James B Rowe; Ian Coyle-Gilchrist; Caroline Graff; Marie Fallström; Vesna Jelic; Anne Kinhult Ståhlbom; Christin Andersson; Håkan Thonberg; Lena Lilius; Giovanni B Frisoni; Michela Pievani; Martina Bocchetta; Luisa Benussi; Roberta Ghidoni; Elizabeth Finger; Sandro Sorbi; Benedetta Nacmias; Gemma Lombardi; Cristina Polito; Jason D Warren; Sebastien Ourselin; Nick C Fox; Martin N Rossor; Giuliano Binetti
Journal:  Lancet Neurol       Date:  2015-02-04       Impact factor: 44.182

6.  Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy.

Authors:  Asami Kondo; Koorosh Shahpasand; Rebekah Mannix; Jianhua Qiu; Juliet Moncaster; Chun-Hau Chen; Yandan Yao; Yu-Min Lin; Jane A Driver; Yan Sun; Shuo Wei; Man-Li Luo; Onder Albayram; Pengyu Huang; Alexander Rotenberg; Akihide Ryo; Lee E Goldstein; Alvaro Pascual-Leone; Ann C McKee; William Meehan; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nature       Date:  2015-07-15       Impact factor: 49.962

Review 7.  NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.

Authors:  Michel Goedert
Journal:  Science       Date:  2015-08-07       Impact factor: 47.728

8.  Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis.

Authors:  Yingjun Zhao; I-Chu Tseng; Charles J Heyser; Edward Rockenstein; Michael Mante; Anthony Adame; Qiuyang Zheng; Timothy Huang; Xin Wang; Pharhad E Arslan; Paramita Chakrabarty; Chengbiao Wu; Guojun Bu; William C Mobley; Yun-Wu Zhang; Peter St George-Hyslop; Eliezer Masliah; Paul Fraser; Huaxi Xu
Journal:  Neuron       Date:  2015-09-02       Impact factor: 17.173

  8 in total
  9 in total

1.  T-complex protein 1-ring complex enhances retrograde axonal transport by modulating tau phosphorylation.

Authors:  Xu-Qiao Chen; Fang Fang; Jazmin B Florio; Edward Rockenstein; Eliezer Masliah; William C Mobley; Robert A Rissman; Chengbiao Wu
Journal:  Traffic       Date:  2018-09-12       Impact factor: 6.215

2.  Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.

Authors:  Sarah L DeVos; Rebecca L Miller; Kathleen M Schoch; Brandon B Holmes; Carey S Kebodeaux; Amy J Wegener; Guo Chen; Tao Shen; Hien Tran; Brandon Nichols; Tom A Zanardi; Holly B Kordasiewicz; Eric E Swayze; C Frank Bennett; Marc I Diamond; Timothy M Miller
Journal:  Sci Transl Med       Date:  2017-01-25       Impact factor: 17.956

3.  CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP.

Authors:  Julio C Rojas; Jee Bang; Iryna V Lobach; Richard M Tsai; Gil D Rabinovici; Bruce L Miller; Adam L Boxer
Journal:  Neurology       Date:  2017-12-27       Impact factor: 9.910

4.  Targeting Pathological Tau by Small Molecule Inhibition of the Poly(A):MSUT2 RNA-Protein Interaction.

Authors:  Jeremy D Baker; Rikki L Uhrich; Timothy J Strovas; Aleen D Saxton; Brian C Kraemer
Journal:  ACS Chem Neurosci       Date:  2020-07-09       Impact factor: 4.418

Review 5.  Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.

Authors:  Maria Stamelou; Gesine Respondek; Nikolaos Giagkou; Jennifer L Whitwell; Gabor G Kovacs; Günter U Höglinger
Journal:  Nat Rev Neurol       Date:  2021-08-23       Impact factor: 42.937

6.  Dyrk1 inhibition improves Alzheimer's disease-like pathology.

Authors:  Caterina Branca; Darren M Shaw; Ramona Belfiore; Vijay Gokhale; Arthur Y Shaw; Christopher Foley; Breland Smith; Christopher Hulme; Travis Dunckley; Bessie Meechoovet; Antonella Caccamo; Salvatore Oddo
Journal:  Aging Cell       Date:  2017-08-04       Impact factor: 9.304

Review 7.  Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology.

Authors:  Congcong Zhang; Rina M Ötjengerdes; Julian Roewe; Rebeca Mejias; Andrea L J Marschall
Journal:  BioDrugs       Date:  2020-08       Impact factor: 5.807

8.  AlphaScreen Identifies MSUT2 Inhibitors for Tauopathy-Targeting Therapeutic Discovery.

Authors:  Jeremy D Baker; Rikki L Uhrich; Timothy J Strovas; Aleen D Saxton; Brian C Kraemer
Journal:  SLAS Discov       Date:  2020-09-28       Impact factor: 3.341

9.  Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer's disease.

Authors:  Fanny M Elahi; Gabe Marx; Yann Cobigo; Adam M Staffaroni; John Kornak; Duygu Tosun; Adam L Boxer; Joel H Kramer; Bruce L Miller; Howard J Rosen
Journal:  Neuroimage Clin       Date:  2017-09-14       Impact factor: 4.881

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.